STOCK TITAN

Nasdaq grants Zentek (NASDAQ: ZTEK) 180-day minimum bid-price extension

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Zentek Ltd. received a further 180‑day extension from Nasdaq to regain compliance with the exchange’s minimum $1.00 bid price requirement for continued listing. The new deadline to meet Nasdaq Listing Rule 5550(a)(2) is August 24, 2026.

The company’s shares will continue to trade on Nasdaq under the symbol “ZTEK” with no immediate impact on listing or trading status. To regain compliance, Zentek must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days on or before the new deadline.

Management plans to monitor the share price and consider available options to satisfy the requirement while continuing to advance its graphene-enabled advanced material technologies across healthcare, clean air and industrial applications.

Positive

  • None.

Negative

  • Nasdaq compliance risk remains: Zentek has only a 180‑day extension, until August 24, 2026, to achieve a closing bid of at least $1.00 for 10 consecutive business days, or its Nasdaq listing could be at risk under the exchange’s rules.

Insights

Nasdaq extension delays, but does not remove, Zentek’s listing risk.

Zentek has secured an additional 180 days, until August 24, 2026, to restore compliance with Nasdaq’s $1.00 minimum bid price rule. This keeps the shares trading under the symbol ZTEK without immediate listing consequences.

The key condition is maintaining a closing bid of at least $1.00 for 10 consecutive business days within the extension window. If this is not achieved, Nasdaq listing status could be at risk under the applicable rules, which would be a meaningful event for investors who value U.S. exchange liquidity.

Management indicates it will monitor the share price and consider available options, but the specific measures are not detailed here. The practical impact will hinge on whether Zentek can meet the 10‑day price test before August 24, 2026 under prevailing market conditions.


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2026

Commission File Number: 001-41310

ZENTEK LTD.

(Registrant)

24 Corporate Court

Guelph, Ontario N1G 5G5 Canada

(Address of Principal Executive Offices)

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☐            Form 40-F  ☒

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  ZENTEK LTD.
  (Registrant)
     
Date: February 25, 2026 By /s/ Wendy Ford
    Wendy Ford
    Chief Financial Officer


EXHIBIT INDEX

Exhibit   Description of Exhibit
   
99.1   Press Release dated February 25, 2026 - Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement



 

Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

Guelph, Ontario, February 25, 2026 - Zentek Ltd. ("Zentek" or the "Company") (TSX-V: ZEN) (NASDAQ: ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on February 23, 2026. The Company now has until August 24, 2026, to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).

There is no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq under the symbol "ZTEK." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to August 24, 2026. Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.

About Zentek Ltd.

Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.

For further information:

Mohammed (Moe) Jiwan

Chief Executive Officer

Phone: 647-287-9582

Email: mjiwan2@zentek.com


To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek refuses any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


FAQ

What did Zentek Ltd. (ZTEK) announce regarding its Nasdaq listing?

Zentek announced that Nasdaq granted a 180‑day extension to regain compliance with the $1.00 minimum bid price rule. The company now has until August 24, 2026, to meet the requirement for continued Nasdaq listing.

What is the new deadline for Zentek (ZTEK) to meet Nasdaq’s $1.00 bid requirement?

Zentek’s new deadline to regain compliance with Nasdaq’s $1.00 minimum bid price rule is August 24, 2026. By that date, the stock must trade at or above $1.00 for 10 consecutive business days.

What conditions must Zentek Ltd. (ZTEK) satisfy to regain Nasdaq compliance?

To regain compliance, Zentek must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days on or before August 24, 2026, as required by Nasdaq Listing Rule 5550(a)(2).

Does the Nasdaq extension immediately affect Zentek (ZTEK) share trading?

The extension has no immediate effect on Zentek’s listing or trading. Its shares will continue to trade on Nasdaq under the symbol ZTEK while the company works to meet the minimum $1.00 bid price requirement.

How does Zentek’s management plan to address the Nasdaq bid price issue?

Zentek’s management plans to actively monitor the bid price of its shares and consider all available options to regain compliance with Nasdaq’s $1.00 minimum bid price requirement before the August 24, 2026 deadline.

What business does Zentek Ltd. (ZTEK) focus on?

Zentek is a Canadian company developing graphene‑enabled advanced material technologies. It targets applications in healthcare, clean air solutions, and next‑generation industrial uses, including potential high‑value markets for ultra‑high‑purity graphite in nuclear, battery, and semiconductor sectors.

Filing Exhibits & Attachments

1 document
Zentek Ltd

NASDAQ:ZTEK

ZTEK Rankings

ZTEK Latest News

ZTEK Latest SEC Filings

ZTEK Stock Data

60.45M
101.39M
Medical Instruments & Supplies
Healthcare
Link
Canada
Guelph